ArticleTheScientificWorldJournal2025
Zero-Dose Vaccination Among Children Aged 12-35 Months in Ethiopia.
Article in TheScientificWorldJournal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Incomplete vaccination among children aged 12-35 months in West Arsi Zone, Ethiopia.BMC pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Immunization is one of the most successful and cost-effective public health interventions worldwide. Approximately 62% of zero-dose children live in just 10 countries, including Ethiopia. In West Arsi Zone, findings from the rapid convenient survey (RCS) were inconsistent with DHIS-2 reports. Objective: The objective was to determine the proportion of zero-dose vaccination and identify associated factors among children aged 12-35 months in West Arsi Zone, June-August 2023. Methods: We conducted a community-based cross-sectional study on 1456 children selected using multistage stratified random sampling. Data were collected through face-to-face interviews with mothers/caretakers and record reviews using an ODK questionnaire. Data were cleaned and analyzed in Stata 16. Binary logistic regression identified factors associated with zero-dose vaccination. Variables with Results: The proportion of zero-dose vaccination was 9.62% (8.10-11.13). The main reasons included unawareness of the need for vaccination (29.57%) and unavailability of the vaccines/vaccinators (15.59%). Factors associated with higher odds of zero-dose vaccination were as follows: living in kebeles where health posts lacked refrigerators (AOR = 2.08, 95% CI: 1.25-3.45), communities without social mobilization for immunization (AOR = 2.63, 95% CI: 1.44-4.80), caregiver unawareness of HEWs (AOR = 1.77, 95% CI: 1.02-3.07), poor immunization knowledge (AOR = 3.08, 95% CI: 1.83-5.21), negative (AOR = 4.24, 95% CI: 2.25-7.97), or neutral attitude (AOR = 4.21, 95% CI: 2.36-7.52) toward immunization, waiting times > 30 min (AOR = 2.83, 95% CI: 1.67-4.97), lack of health education at the facility (AOR = 2.48, 95% CI: 1.44-4.27), mothers with no ANC (AOR = 4.08, 95% CI: 2.32-7.16), home delivery (AOR = 4.07, 95% CI: 2.30-7.20), and female children (AOR = 1.75, 95% CI: 1.10-2.78). Conclusions: Zero-dose vaccination is consistent with RCS findings and is unacceptably high compared to the national targets (100% Pentavalent 1 coverage nationally; 98% per district). Interventions should focus on increasing community awareness, ensuring vaccines and vaccinator availability, and promoting equal care for male and female children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.